Updated Jul 16, 2026
Pennell Sandra is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $50K.
Sandra Pennell is associated with Delcath Systems, Inc., a company focused on innovative cancer treatment solutions. Specific details about her role or contributions are not widely documented in public sources.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-06 | DCTH | DELCATH SYSTEMS, INC. | P — Open-market purchase | 5.5K | $9.04 | $50K |
Sandra Pennell is associated with Delcath Systems, Inc., a company focused on innovative cancer treatment solutions. Specific details about her role or contributions are not widely documented in public sources.…
Recorded transactions: 1 open-market purchases ($50K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Pennell Sandra profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.